Summit Therapeutics Inc.

21.69
-1.81 (-7.70%)
At close: Jan 29, 2025, 3:59 PM
21.79
0.46%
After-hours Jan 29, 2025, 07:59 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03
Net Income -614.93M -78.78M -88.60M -52.70M -23.88M 6.60M -15.42M -32.13M -28.69M -19.07M -11.05M -7.21M -4.71M -9.38M -6.79M -35.09M -23.40M -8.60M -3.21M -536.61K -43.79K
Depreciation & Amortization 2.05M 2.51M 2.46M 2.00M 1.39M 1.49M 348.20K 72.50K 68.36K 49.72K 42.89K 146.89K 295.22K 710.54K 3.78M 2.74M 3.28M 737.53K 240.99K 9.41K n/a
Stock-Based Compensation 14.11M 9.88M 9.47M 1.29M 542.05K 6.22M 2.27M 1.72M 1.65M 1.45M 372.79K 181.64K 97.36K 117.11K -28.76K 305.55K 966.41K 792.45K 119.60K n/a n/a
Other Working Capital -9.16M 11.77M -813.00K 5.37M -2.68M n/a n/a 39.79M 811.79K -501.73K 659.80K 108.18K 92.97K 3.64M 754.07K 15.94M 2.36M 1.09M 317.75K 178.87K n/a
Other Non-Cash Items 524.38M 14.12M 497.00K -385.00K 5.12M 1.73M 3.47M 1.06M -105.39K -135.60K 295.26K 1.79M 471.09K 582.36K -648.62K 1.46M 827.22K 329.53K 51.77K 0.00 -100.35K
Deferred Income Tax n/a n/a 326.00K 583.00K 309.13K 2.97 n/a 4.66M 1.79M 1.15M 357.94K 1.80M 386.09K 1.96M 1.24M 1.46M 3.28M 2.67M 410.57K n/a n/a
Change in Working Capital -2.37M 8.62M -67.00K 619.00K 955.98K -51.18M -11.47M 39.79M 811.79K -501.73K 659.80K 63.18K 43.97K 3.64M 1.04M 15.86M 2.20M 776.76K 269.55K 178.87K 142.31K
Operating Cash Flow -76.76M -41.58M -72.59M -48.11M -15.56M -35.14M -20.79M 15.18M -24.47M -17.06M -9.68M -5.03M -3.81M -4.33M -2.65M -14.72M -16.13M -5.96M -2.53M -348.33K -1.82K
Capital Expenditures -128.00K -624.00K -306.00K -421.00K -265.33K -163.95K -678.01K -110.00K -94.00K -52.73K -77.53K -120.04K -190.01K -193.07K -140.59K -1.65M -3.86M -3.37M -2.45M -11.30K n/a
Acquisitions n/a n/a n/a n/a -99.19K -251.82K -6.76M n/a n/a n/a n/a n/a n/a n/a n/a n/a 807.33K -500.19K n/a n/a n/a
Purchase of Investments -321.02M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments 208.16M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies -474.79M -600 n/a n/a 11.95K 5.25K 16.98K 10.00K 42.73K 76.84K 166.60K -50.54K 17.27K 22.16K 25.56K 438.15K 1.54M 1.55M 4.84M -25.58M n/a
Investing Cash Flow -587.77M -624.00K -306.00K -421.00K -265.33K -410.52K -7.42M -100.00K -51.27K 24.11K 105.57K -102.67K -172.73K -170.91K -115.03K -1.22M -1.52M -2.32M 2.39M -25.59M n/a
Debt Repayment -24.69M 520.00M n/a n/a n/a -368.55K -181.18K 23.00K n/a -316.00K n/a n/a n/a n/a -84.67K -294.02K 1.05M -182.42K 1.35M n/a n/a
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 106.20M 100.24M 2.92M 551.00K 37.46M -1.21M -7.05M 493.23K -5.65M -1.88M -3.24M -702.88K -938.78K -6.33K -894.65K -14.41K 1.00 -0.1 n/a n/a 182.45K
Financial Cash Flow 86.51M 620.24M 77.92M 50.55M 37.46M 43.85M 19.68M 516.23K 22.14M 30.95M 7.35M 7.19M 2.14M 22.16K 8.14M 5.31M 1.33M 19.38M 1.35M 26.47M 182.45K
Net Cash Flow -577.18M 576.82M 5.37M 2.58M 27.70M 8.86M -11.27M 14.70M 7.18M 13.91M -2.23M 2.06M -1.84M -4.48M 5.38M -10.62M -16.31M 11.09M -20.01M -25.60M 180.62K
Free Cash Flow -76.89M -42.21M -72.89M -48.53M -15.83M -35.31M -21.47M 15.07M -24.56M -17.12M -9.76M -5.15M -4.00M -4.53M -2.79M -16.37M -19.99M -9.33M -4.98M -359.62K -1.82K